These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 33186855)

  • 1. PCSK9 post-transcriptional regulation: Role of a 3'UTR microRNA-binding site variant in linkage disequilibrium with c.1420G.
    Decourt C; Janin A; Moindrot M; Chatron N; Nony S; Muntaner M; Dumont S; Divry E; Dauchet L; Meirhaeghe A; Marmontel O; Bardel C; Charrière S; Cariou B; Moulin P; Di Filippo M
    Atherosclerosis; 2020 Dec; 314():63-70. PubMed ID: 33186855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional analysis of
    Los B; Borges JB; Oliveira VF; Freitas RC; Dagli-Hernandez C; Bortolin RH; Gonçalves RM; Faludi AA; Rodrigues AC; Bastos GM; Jannes CE; Pereira AC; Hirata RD; Hirata MH
    Epigenomics; 2021 May; 13(10):779-791. PubMed ID: 33899508
    [No Abstract]   [Full Text] [Related]  

  • 3. microRNA-483 ameliorates hypercholesterolemia by inhibiting PCSK9 production.
    Dong J; He M; Li J; Pessentheiner A; Wang C; Zhang J; Sun Y; Wang WT; Zhang Y; Liu J; Wang SC; Huang PH; Gordts PL; Yuan ZY; Tsimikas S; Shyy JY
    JCI Insight; 2020 Dec; 5(23):. PubMed ID: 33119548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple microRNA regulation of lipoprotein lipase gene abolished by 3'UTR polymorphisms in a triglyceride-lowering haplotype harboring p.Ser474Ter.
    Caussy C; Charrière S; Meirhaeghe A; Dallongeville J; Lefai E; Rome S; Cuerq C; Euthine V; Delay M; Marmontel O; Di Filippo M; Lagarde M; Moulin P; Marçais C
    Atherosclerosis; 2016 Mar; 246():280-6. PubMed ID: 26820803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interplay between microRNAs, Serum Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9), and Lipid Parameters in Patients with Very High Lipoprotein(a) Treated with PCSK9 Inhibitors.
    Levstek T; Karun T; Rehberger Likozar A; Šebeštjen M; Trebušak Podkrajšek K
    Genes (Basel); 2023 Mar; 14(3):. PubMed ID: 36980904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of evidence for a liver or intestinal miRNA regulation involved in the hypertriglyceridemic effect of APOC3 3'UTR variant SstI.
    Dancer M; Caussy C; Di Filippo M; Moulin P; Marçais C; Charrière S
    Atherosclerosis; 2016 Dec; 255():6-10. PubMed ID: 27794214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-337-3p lowers serum LDL-C level through targeting PCSK9 in hyperlipidemic mice.
    Xu X; Dong Y; Ma N; Kong W; Yu C; Gong L; Chen J; Ren J
    Metabolism; 2021 Jun; 119():154768. PubMed ID: 33775647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment-Induced Viral Cure of Hepatitis C Virus-Infected Patients Involves a Dynamic Interplay among three Important Molecular Players in Lipid Homeostasis: Circulating microRNA (miR)-24, miR-223, and Proprotein Convertase Subtilisin/Kexin Type 9.
    Hyrina A; Olmstead AD; Steven P; Krajden M; Tam E; Jean F
    EBioMedicine; 2017 Sep; 23():68-78. PubMed ID: 28864162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fixed differences in the 3'UTR of buffalo PRNP gene provide binding sites for miRNAs post-transcriptional regulation.
    Zhao H; Wang S; Guo L; Du Y; Liu L; Ma T; Otecko NO; Li C; Zhang Y
    Oncotarget; 2017 Jul; 8(28):46006-46019. PubMed ID: 28545018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of 3'UTR genetic variants in PCSK9 and LDLR genes on plasma lipid traits and response to atorvastatin in Brazilian subjects: a pilot study.
    Zambrano T; Hirata MH; Cerda Á; Dorea EL; Pinto GA; Gusukuma MC; Bertolami MC; Salazar LA; Hirata RD
    Int J Clin Exp Med; 2015; 8(4):5978-88. PubMed ID: 26131194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a functional FADS1 3'UTR variant associated with erythrocyte n-6 polyunsaturated fatty acids levels.
    Hermant X; Delay C; Flaig A; Luque-Bedregal J; Briand G; Bout MA; Cottel D; Wagner A; Arveiler D; Simon C; Ferrières J; Ruidavets JB; Laillet B; Amouyel P; Dallongeville J; Meirhaeghe A; Dumont J
    J Clin Lipidol; 2018; 12(5):1280-1289. PubMed ID: 30170993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SNPs at 3'UTR of APOL1 and miR-6741-3p target sites associated with kidney diseases more susceptible to SARS-COV-2 infection: in silco and in vitro studies.
    Safdar M; Khan MS; Karim AY; Omar SA; Smail SW; Saeed M; Zaheer S; Ali M; Ahmad B; Tasleem M; Junejo Y
    Mamm Genome; 2021 Oct; 32(5):389-400. PubMed ID: 34089082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A 3'UTR polymorphism marks differential KLRG1 mRNA levels through disruption of a miR-584-5p binding site and associates with pemphigus foliaceus susceptibility.
    Cipolla GA; Park JK; de Oliveira LA; Lobo-Alves SC; de Almeida RC; Farias TD; Lemos Dde S; Malheiros D; Lavker RM; Petzl-Erler ML
    Biochim Biophys Acta; 2016 Oct; 1859(10):1306-13. PubMed ID: 27424220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain derived neurotrophic factor (BDNF) expression is regulated by microRNAs miR-26a and miR-26b allele-specific binding.
    Caputo V; Sinibaldi L; Fiorentino A; Parisi C; Catalanotto C; Pasini A; Cogoni C; Pizzuti A
    PLoS One; 2011; 6(12):e28656. PubMed ID: 22194877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The rs17084733 variant in the
    Ravegnini G; Serrano C; Simeon V; Sammarini G; Nannini M; Roversi E; Urbini M; Ferrè F; Ricci R; Tarantino G; Pantaleo MA; Hrelia P; Angelini S
    Epigenetics; 2019 Jun; 14(6):545-557. PubMed ID: 30983504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A variant in a microRNA binding site in NEIL2 3'UTR confers susceptibility to age-related cataracts.
    Kang L; Zou X; Zhang G; Xiang J; Wang Y; Yang M; Chen X; Wu J; Guan H
    FASEB J; 2019 Sep; 33(9):10469-10476. PubMed ID: 31253066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A GDF15 3' UTR variant, rs1054564, results in allele-specific translational repression of GDF15 by hsa-miR-1233-3p.
    Teng MS; Hsu LA; Juan SH; Lin WC; Lee MC; Su CW; Wu S; Ko YL
    PLoS One; 2017; 12(8):e0183187. PubMed ID: 28806401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclase-associated protein 1 is a binding partner of proprotein convertase subtilisin/kexin type-9 and is required for the degradation of low-density lipoprotein receptors by proprotein convertase subtilisin/kexin type-9.
    Jang HD; Lee SE; Yang J; Lee HC; Shin D; Lee H; Lee J; Jin S; Kim S; Lee SJ; You J; Park HW; Nam KY; Lee SH; Park SW; Kim JS; Kim SY; Kwon YW; Kwak SH; Yang HM; Kim HS
    Eur Heart J; 2020 Jan; 41(2):239-252. PubMed ID: 31419281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of fifteen novel germline variants in the BRCA1 3'UTR reveals a variant in a breast cancer case that introduces a functional miR-103 target site.
    Brewster BL; Rossiello F; French JD; Edwards SL; Wong M; Wronski A; Whiley P; Waddell N; Chen X; Bove B; ; Hopper JL; John EM; Andrulis I; Daly M; Volorio S; Bernard L; Peissel B; Manoukian S; Barile M; Pizzamiglio S; Verderio P; Spurdle AB; Radice P; Godwin AK; Southey MC; Brown MA; Peterlongo P
    Hum Mutat; 2012 Dec; 33(12):1665-75. PubMed ID: 22753153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrative mutation, haplotype and G × G interaction evidence connects ABGL4, LRP8 and PCSK9 genes to cardiometabolic risk.
    Guo T; Yin RX; Yao LM; Huang F; Pan L; Lin WX; Yang DZ; Pan SL
    Sci Rep; 2016 Nov; 6():37375. PubMed ID: 27853278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.